|
KYNB Kyntra Bio Inc 921299 |
| Balance Sheet |
|
Current Assets
|
$96,825,000.00 |
|
Assets
|
$101,078,000.00 |
|
Current Liabilities
|
$36,040,000.00 |
|
Liabilities
|
$109,222,000.00 |
|
Equity
|
$-30,144,000.00 |
|
Shares Out
|
4049000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-17,878,000.00 |
|
Investing Cash Flow
|
$20,691,000.00 |
| Market Analysis |
Market Cap
|
$29,638,680.00 |
|
Price
|
$7.32 |
|
PB
|
22.50 |
|
EPS
|
2.96 |
|
PE
|
0.18 |
|
PS
|
2.07 |
|
FCF
|
$-17,878,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-3.61 |
|
|
2026-05-11 |
-3.74 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KYNB documents filed with the SEC.
KYNB Filings
Clear
